Learn more.<\/a><\/p>\n<\/span>\n <\/li>\n<\/ul><\/div>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"
A rare neurological emergency is reappearing in an unexpected place. Wernicke encephalopathy is a fast-moving brain disorder that emerges when cellular energy production breaks down, leaving your brain unable to function normally. Think of your brain as a city that runs entirely on electricity. Wernicke encephalopathy is what happens when the power grid starts failing \u2014 first in scattered neighborhoods, then spreading outward.<\/p>\n
The areas controlling balance, eye movement, and clear thinking go dark first because they’re the most energy-hungry. What raises concern now is not the disorder itself, but the pattern behind recent cases. Powerful GLP-1 weight loss drugs like Ozempic have entered widespread use, and alongside that growth, clinicians have begun flagging severe neurological outcomes that don’t fit the usual risk profile.<\/p>\n
Millions of people now rely on these injections to suppress appetite and drive rapid weight loss, often without understanding what prolonged appetite shutdown does to nutrient status and energy metabolism. At the center of this issue sits a simple but overlooked truth: your brain is the most fuel-hungry organ in your body, consuming 20% of your daily energy despite weighing only 2% of your body weight.<\/p>\n
Cut the fuel supply, and it’s the first organ to suffer. When food intake collapses and digestion slows for weeks or months, the systems that convert glucose into energy begin to fail. Early warning signs often look vague and easy to dismiss, which is exactly why damage progresses before anyone realizes what’s happening.<\/p>\n
This is where a gut-centered approach adds to the conversation. In my book, “Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,” I explore general lifestyle and nutrition concepts related to digestive health and metabolism. The book is intended for educational purposes only and does not claim to diagnose, treat, cure, or prevent any disease. Individual results may vary.<\/p>\n
A Rare Neurological Risk Surfaces in GLP-1 Drug Users<\/p>\n
A study published in Clinical Nutrition explored whether GLP-1 receptor agonist drugs used for weight loss and diabetes are associated with Wernicke encephalopathy, a severe neurological disorder tied to vitamin B1 deficiency.1<\/p>\n
The researchers analyzed real-world safety data from the U.S. Food and Drug Administration’s (FDA) Adverse Event Reporting System and paired it with a structured review of published medical cases, which allows rare but serious harms to surface even when they don’t appear in trials.<\/p>\n
\u2022 Researchers found 15 documented cases of Wernicke encephalopathy linked to GLP-1 drug use \u2014 Of them, 13 were reported through the FDA database, one from the medical literature, and one from the researchers’ own hospital experience. Most reports clustered in 2023 and 2024, which mirrors the explosive rise in GLP-1 prescriptions. Reports of Wernicke encephalopathy were more than twice as likely with GLP-1 drugs compared with other medications.<\/p>\n
\u2022 Nearly every affected patient shared the same risk profile \u2014 Thirteen of the 15 individuals experienced severe gastrointestinal symptoms such as persistent vomiting, appetite loss, rapid weight loss, or malnutrition before neurological symptoms appeared. The study emphasizes that GLP-1 drugs slow gastric emptying and suppress appetite, which increases the likelihood of prolonged nutrient depletion.<\/p>\n
\u2022 Certain drugs appeared far more often than others \u2014 Eight of the 15 cases involved semaglutide, marketed as Ozempic or Wegovy, and six involved tirzepatide, sold under the brand name Mounjaro.2<\/p>\n
\u2022 Classic neurological symptoms were often incomplete, which delayed diagnosis \u2014 Only two patients showed the full textbook triad of confusion, eye movement problems, and gait instability. Eleven showed partial symptoms, and some showed none at first. This matters because clinicians often wait for obvious signs before testing or treating vitamin B1 deficiency.<\/p>\n
Unlike fat-soluble vitamins that your body stores for months, vitamin B1 is water-soluble with minimal reserves \u2014 your body holds only about 30 milligrams at any time, enough for roughly two to three weeks. During rapid weight loss, metabolic demands actually increase while intake plummets, depleting stores at an accelerated rate.<\/p>\n
Among the 11 patients with follow-up data, seven were left with permanent neurological damage despite treatment. That means more than half experienced lasting harm that did not resolve even after vitamin B1 replacement.<\/p>\n
\u2022 The study highlights a glaring gap in current medical practice \u2014 Despite decades of awareness that rapid weight loss and vomiting trigger vitamin B1 deficiency in bariatric surgery patients, no formal guidelines require routine vitamin monitoring for people taking GLP-1 drugs for weight loss.<\/p>\n
For those taking GLP-1 drugs, recognizing early warning signs such as ongoing nausea, dizziness, confusion, or trouble walking allows timely vitamin B1 testing and treatment, which may reverse symptoms when done early. But the study raises a deeper question: why does B1 depletion cause such catastrophic damage so quickly? A commentary by bioenergetic researcher Georgi Dinkov provides the missing mechanistic piece.3<\/p>\n
Why Energy Failure, Not Weight Loss, Drives the Real Danger<\/p>\n
In his commentary, Dinkov examines why vitamin B1 depletion creates cascading damage inside your brain and body once GLP-1 drugs suppress food intake and trigger prolonged vomiting. Dinkov explains that vitamin B1 controls pyruvate dehydrogenase (PDH), which acts like a metabolic turnstile at your cells’ power plants.<\/p>\n
When B1 is adequate, PDH lets glucose pass through to produce clean, efficient energy. When B1 runs low, glucose gets diverted into an emergency backup pathway that produces lactic acid instead \u2014 the same substance that makes muscles burn during intense exercise. Except now it’s building up in your brain.<\/p>\n
\u2022 Lactic acid builds up rapidly when PDH function drops \u2014 Impaired PDH activity forces glucose to convert into lactate instead of entering normal energy pathways. Lactate buildup damages tissues directly, especially in your brain and heart, and creates an internal acidic environment that cells struggle to survive.
\n\u2022 The health consequences extend far beyond neurological symptoms alone. Dinkov links reduced PDH activity to a range of disorders, including depression, psychosis, diabetes, heart disease, and cancer, all tied to impaired glucose oxidation.
\nOnce lactic acid accumulates to dangerous levels, outcomes deteriorate fast. Severe lactic acidosis carries a reported mortality rate of 30% to 40% even with hospital treatment, which places metabolic collapse among the most lethal downstream effects of B1 depletion.
\n\u2022 The risks don’t disappear when symptoms look mild \u2014 Dinkov notes that even partial suppression of vitamin B1 activity still disrupts PDH function. Lower drug doses that blunt appetite without extreme vomiting still create metabolic stress that compounds over time.<\/p>\n
\u2022 Multiple established GLP-1 side effects intensify metabolic stress \u2014 Beyond appetite suppression, GLP-1 drugs associate with gastroparesis (delayed stomach emptying), vision loss, and other neurological complications, all of which reflect impaired energy production in tissues with high fuel demand.
\nDelayed stomach emptying prolongs nausea, early fullness, and nutrient depletion, while visual damage signals ongoing metabolic failure in your nervous system. For patients, persistent digestive or sensory symptoms are not harmless trade-offs; they show that the metabolic imbalance driving harm remains active and uncorrected.<\/p>\n
How to Lose Weight Without Wrecking Your Metabolism<\/p>\n
Questions about long-term health often lead to broader discussions about lifestyle and metabolism. In my book, “Weight Loss Cure,” I explore general concepts related to nutrition, digestive health, and their role in metabolic function, from an educational perspective. The content does not provide medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical treatment decisions.<\/p>\n
1. Stop using GLP-1 drugs and remove the metabolic stressor \u2014 If you’re taking a GLP-1 drug, stopping it removes the constant pressure that suppresses appetite, slows digestion, and drains nutrients. Once that stress lifts, your body reallocates resources toward repair instead of survival. This single step protects your brain, stabilizes energy production, and prevents further nutrient depletion that drives neurological injury.<\/p>\n
2. Use a GLP-1 strategy that works with your biology, not against it \u2014 A biology-informed approach can encourage broader conversations about metabolism. In my book, “Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,” I explore general lifestyle, nutrition, and digestive health concepts and their relationship to metabolic function.
\nThe book is educational in nature and does not claim to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical or treatment decisions.<\/p>\n
3. Repair your gut so Akkermansia regulates appetite naturally \u2014 Akkermansia muciniphila is a key gut bacterium that helps trigger your body’s own GLP-1 release through proteins it naturally secretes. When your gut barrier is damaged by seed oils, inflammation, and metabolic stress, this system shuts down. Fixing gut integrity first restores steady appetite control without malnutrition or energy failure. If your gut is not stable, repair comes before adding fiber or supplements.<\/p>\n
You might wonder what seed oils have to do with vitamin B1 and brain health. The connection is mitochondrial function. Seed oils high in linoleic acid (LA) create oxidative stress in your mitochondria \u2014 the same cellular power plants that B1 helps run. Eliminating one stressor while addressing another creates compounding benefits for energy production.<\/p>\n
4. Create an environment where beneficial gut bacteria thrive \u2014 Eliminating seed oils high in LA reduces mitochondrial stress and gut inflammation, which allows Akkermansia to take hold. Aim to keep daily LA intake under 5 grams, ideally closer to 2 grams. When my Pax health coaching platform launches, the Seed Oil Sleuth feature will help you track this down to the tenth of a gram.<\/p>\n
Replace seed oils with grass fed butter, ghee, or tallow. After your digestion stabilizes, introduce polyphenol-rich foods such as berries and gentle inulin sources like leeks or garlic. Think of gut repair as building a house: you wouldn’t install cabinets before the foundation is set. Each step creates the conditions for the next to succeed.<\/p>\n
5. Restore protein and carbohydrates to rebuild energy and tissue \u2014 If your appetite stayed low for weeks or months, your body has been running on a deficit. Increase protein slowly until intake reaches about 0.8 grams per pound of ideal body weight (or about 1.76 grams per kilogram), with roughly one-third from collagen-rich sources such as bone broth, natural gelatin, oxtail, or connective-tissue-rich beef.<\/p>\n
Pair this with gradual carbohydrate reintroduction, starting with easy-to-digest options like fruit or white rice before moving to more complex carbs. Adequate glucose signals safety to your metabolism. Without it, your body stays in crisis mode \u2014 hoarding resources rather than investing them in repair. This is why low-carb diets often backfire during recovery.<\/p>\n
FAQs About GLP-1 Drugs and Neurological Risks<\/p>\n
Q: What is the main neurological risk linked to GLP-1 weight loss drugs?
\nA: Recent clinical reports link GLP-1 drugs to Wernicke encephalopathy, a fast-moving brain disorder caused by severe vitamin B1 deficiency. When appetite suppression and slowed digestion persist, your brain loses the fuel it needs to function, leading to confusion, balance problems, vision changes, and lasting neurological damage.<\/p>\n
Q: Why do GLP-1 drugs increase the risk of vitamin B1 depletion?
\nA: GLP-1 drugs suppress appetite and slow stomach emptying, which sharply reduces food intake and nutrient absorption over time. Prolonged nausea, vomiting, and early fullness drain vitamin B1 stores quickly, especially during rapid weight loss, setting the stage for energy failure in your brain.<\/p>\n
Q: Are these risks limited to high doses or severe side effects?
\nA: No. Even lower doses that blunt appetite without obvious vomiting still create metabolic stress. Research and metabolic analysis show that partial nutrient depletion disrupts energy production and compounds damage over time, even when symptoms seem mild.<\/p>\n
Q: What warning signs shouldn’t be ignored while using GLP-1 drugs?
\nA: Persistent nausea, dizziness, confusion, trouble walking, vision changes, or extreme fatigue deserve immediate attention. These symptoms signal that energy metabolism is compromised and neurological injury may already be underway.<\/p>\n
Q: How can weight loss happen without these risks?
\nA: Conversations about weight and metabolism often include the role of digestion, nutrition, and overall metabolic health. In my book, “Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,” I explore lifestyle and dietary concepts related to gut health, metabolism, and nutritional balance as part of an educational discussion. The book is intended for informational purposes only and does not provide medical advice or claim to diagnose, treat, cure, or prevent any disease.<\/p>\n
Test Your Knowledge with Today’s Quiz!
\nTake today\u2019s quiz to see how much you\u2019ve learned from yesterday\u2019s Mercola.com article.<\/p>\n
What part of the retina allows you to read fine print and recognize faces?<\/p>\n
Optic nerve
\n Retina periphery
\n Macular layer
\n Foveola
\n The foveola is the central part of the retina that provides the sharpest, most detailed vision, enabling tasks like reading and facial recognition. Learn more.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"seo_booster_metabox":"","footnotes":""},"categories":[3562,3892],"tags":[],"class_list":["post-164052","post","type-post","status-publish","format-standard","hentry","category-baptism-confirmation","category-dr-mercola-daily-news"],"yoast_head":"\n
GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News\" \/>\n<meta property=\"og:description\" content=\"A rare neurological emergency is reappearing in an unexpected place. Wernicke encephalopathy is a fast-moving brain disorder that emerges when cellular energy production breaks down, leaving your brain unable to function normally. Think of your brain as a city that runs entirely on electricity. Wernicke encephalopathy is what happens when the power grid starts failing \u2014 first in scattered neighborhoods, then spreading outward. The areas controlling balance, eye movement, and clear thinking go dark first because they're the most energy-hungry. What raises concern now is not the disorder itself, but the pattern behind recent cases. Powerful GLP-1 weight loss drugs like Ozempic have entered widespread use, and alongside that growth, clinicians have begun flagging severe neurological outcomes that don't fit the usual risk profile. Millions of people now rely on these injections to suppress appetite and drive rapid weight loss, often without understanding what prolonged appetite shutdown does to nutrient status and energy metabolism. At the center of this issue sits a simple but overlooked truth: your brain is the most fuel-hungry organ in your body, consuming 20% of your daily energy despite weighing only 2% of your body weight. Cut the fuel supply, and it's the first organ to suffer. When food intake collapses and digestion slows for weeks or months, the systems that convert glucose into energy begin to fail. Early warning signs often look vague and easy to dismiss, which is exactly why damage progresses before anyone realizes what's happening. This is where a gut-centered approach adds to the conversation. In my book, "Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1," I explore general lifestyle and nutrition concepts related to digestive health and metabolism. The book is intended for educational purposes only and does not claim to diagnose, treat, cure, or prevent any disease. Individual results may vary. A Rare Neurological Risk Surfaces in GLP-1 Drug Users A study published in Clinical Nutrition explored whether GLP-1 receptor agonist drugs used for weight loss and diabetes are associated with Wernicke encephalopathy, a severe neurological disorder tied to vitamin B1 deficiency.1 The researchers analyzed real-world safety data from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System and paired it with a structured review of published medical cases, which allows rare but serious harms to surface even when they don't appear in trials. \u2022 Researchers found 15 documented cases of Wernicke encephalopathy linked to GLP-1 drug use \u2014 Of them, 13 were reported through the FDA database, one from the medical literature, and one from the researchers' own hospital experience. Most reports clustered in 2023 and 2024, which mirrors the explosive rise in GLP-1 prescriptions. Reports of Wernicke encephalopathy were more than twice as likely with GLP-1 drugs compared with other medications. \u2022 Nearly every affected patient shared the same risk profile \u2014 Thirteen of the 15 individuals experienced severe gastrointestinal symptoms such as persistent vomiting, appetite loss, rapid weight loss, or malnutrition before neurological symptoms appeared. The study emphasizes that GLP-1 drugs slow gastric emptying and suppress appetite, which increases the likelihood of prolonged nutrient depletion. \u2022 Certain drugs appeared far more often than others \u2014 Eight of the 15 cases involved semaglutide, marketed as Ozempic or Wegovy, and six involved tirzepatide, sold under the brand name Mounjaro.2 \u2022 Classic neurological symptoms were often incomplete, which delayed diagnosis \u2014 Only two patients showed the full textbook triad of confusion, eye movement problems, and gait instability. Eleven showed partial symptoms, and some showed none at first. This matters because clinicians often wait for obvious signs before testing or treating vitamin B1 deficiency. Unlike fat-soluble vitamins that your body stores for months, vitamin B1 is water-soluble with minimal reserves \u2014 your body holds only about 30 milligrams at any time, enough for roughly two to three weeks. During rapid weight loss, metabolic demands actually increase while intake plummets, depleting stores at an accelerated rate. Among the 11 patients with follow-up data, seven were left with permanent neurological damage despite treatment. That means more than half experienced lasting harm that did not resolve even after vitamin B1 replacement. \u2022 The study highlights a glaring gap in current medical practice \u2014 Despite decades of awareness that rapid weight loss and vomiting trigger vitamin B1 deficiency in bariatric surgery patients, no formal guidelines require routine vitamin monitoring for people taking GLP-1 drugs for weight loss. For those taking GLP-1 drugs, recognizing early warning signs such as ongoing nausea, dizziness, confusion, or trouble walking allows timely vitamin B1 testing and treatment, which may reverse symptoms when done early. But the study raises a deeper question: why does B1 depletion cause such catastrophic damage so quickly? A commentary by bioenergetic researcher Georgi Dinkov provides the missing mechanistic piece.3 Why Energy Failure, Not Weight Loss, Drives the Real Danger In his commentary, Dinkov examines why vitamin B1 depletion creates cascading damage inside your brain and body once GLP-1 drugs suppress food intake and trigger prolonged vomiting. Dinkov explains that vitamin B1 controls pyruvate dehydrogenase (PDH), which acts like a metabolic turnstile at your cells' power plants. When B1 is adequate, PDH lets glucose pass through to produce clean, efficient energy. When B1 runs low, glucose gets diverted into an emergency backup pathway that produces lactic acid instead \u2014 the same substance that makes muscles burn during intense exercise. Except now it's building up in your brain. \u2022 Lactic acid builds up rapidly when PDH function drops \u2014 Impaired PDH activity forces glucose to convert into lactate instead of entering normal energy pathways. Lactate buildup damages tissues directly, especially in your brain and heart, and creates an internal acidic environment that cells struggle to survive. \u2022 The health consequences extend far beyond neurological symptoms alone. Dinkov links reduced PDH activity to a range of disorders, including depression, psychosis, diabetes, heart disease, and cancer, all tied to impaired glucose oxidation. Once lactic acid accumulates to dangerous levels, outcomes deteriorate fast. Severe lactic acidosis carries a reported mortality rate of 30% to 40% even with hospital treatment, which places metabolic collapse among the most lethal downstream effects of B1 depletion. \u2022 The risks don't disappear when symptoms look mild \u2014 Dinkov notes that even partial suppression of vitamin B1 activity still disrupts PDH function. Lower drug doses that blunt appetite without extreme vomiting still create metabolic stress that compounds over time. \u2022 Multiple established GLP-1 side effects intensify metabolic stress \u2014 Beyond appetite suppression, GLP-1 drugs associate with gastroparesis (delayed stomach emptying), vision loss, and other neurological complications, all of which reflect impaired energy production in tissues with high fuel demand. Delayed stomach emptying prolongs nausea, early fullness, and nutrient depletion, while visual damage signals ongoing metabolic failure in your nervous system. For patients, persistent digestive or sensory symptoms are not harmless trade-offs; they show that the metabolic imbalance driving harm remains active and uncorrected. How to Lose Weight Without Wrecking Your Metabolism Questions about long-term health often lead to broader discussions about lifestyle and metabolism. In my book, "Weight Loss Cure," I explore general concepts related to nutrition, digestive health, and their role in metabolic function, from an educational perspective. The content does not provide medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical treatment decisions. 1. Stop using GLP-1 drugs and remove the metabolic stressor \u2014 If you're taking a GLP-1 drug, stopping it removes the constant pressure that suppresses appetite, slows digestion, and drains nutrients. Once that stress lifts, your body reallocates resources toward repair instead of survival. This single step protects your brain, stabilizes energy production, and prevents further nutrient depletion that drives neurological injury. 2. Use a GLP-1 strategy that works with your biology, not against it \u2014 A biology-informed approach can encourage broader conversations about metabolism. In my book, "Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1," I explore general lifestyle, nutrition, and digestive health concepts and their relationship to metabolic function. The book is educational in nature and does not claim to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical or treatment decisions. 3. Repair your gut so Akkermansia regulates appetite naturally \u2014 Akkermansia muciniphila is a key gut bacterium that helps trigger your body's own GLP-1 release through proteins it naturally secretes. When your gut barrier is damaged by seed oils, inflammation, and metabolic stress, this system shuts down. Fixing gut integrity first restores steady appetite control without malnutrition or energy failure. If your gut is not stable, repair comes before adding fiber or supplements. You might wonder what seed oils have to do with vitamin B1 and brain health. The connection is mitochondrial function. Seed oils high in linoleic acid (LA) create oxidative stress in your mitochondria \u2014 the same cellular power plants that B1 helps run. Eliminating one stressor while addressing another creates compounding benefits for energy production. 4. Create an environment where beneficial gut bacteria thrive \u2014 Eliminating seed oils high in LA reduces mitochondrial stress and gut inflammation, which allows Akkermansia to take hold. Aim to keep daily LA intake under 5 grams, ideally closer to 2 grams. When my Pax health coaching platform launches, the Seed Oil Sleuth feature will help you track this down to the tenth of a gram. Replace seed oils with grass fed butter, ghee, or tallow. After your digestion stabilizes, introduce polyphenol-rich foods such as berries and gentle inulin sources like leeks or garlic. Think of gut repair as building a house: you wouldn't install cabinets before the foundation is set. Each step creates the conditions for the next to succeed. 5. Restore protein and carbohydrates to rebuild energy and tissue \u2014 If your appetite stayed low for weeks or months, your body has been running on a deficit. Increase protein slowly until intake reaches about 0.8 grams per pound of ideal body weight (or about 1.76 grams per kilogram), with roughly one-third from collagen-rich sources such as bone broth, natural gelatin, oxtail, or connective-tissue-rich beef. Pair this with gradual carbohydrate reintroduction, starting with easy-to-digest options like fruit or white rice before moving to more complex carbs. Adequate glucose signals safety to your metabolism. Without it, your body stays in crisis mode \u2014 hoarding resources rather than investing them in repair. This is why low-carb diets often backfire during recovery. FAQs About GLP-1 Drugs and Neurological Risks Q: What is the main neurological risk linked to GLP-1 weight loss drugs? A: Recent clinical reports link GLP-1 drugs to Wernicke encephalopathy, a fast-moving brain disorder caused by severe vitamin B1 deficiency. When appetite suppression and slowed digestion persist, your brain loses the fuel it needs to function, leading to confusion, balance problems, vision changes, and lasting neurological damage. Q: Why do GLP-1 drugs increase the risk of vitamin B1 depletion? A: GLP-1 drugs suppress appetite and slow stomach emptying, which sharply reduces food intake and nutrient absorption over time. Prolonged nausea, vomiting, and early fullness drain vitamin B1 stores quickly, especially during rapid weight loss, setting the stage for energy failure in your brain. Q: Are these risks limited to high doses or severe side effects? A: No. Even lower doses that blunt appetite without obvious vomiting still create metabolic stress. Research and metabolic analysis show that partial nutrient depletion disrupts energy production and compounds damage over time, even when symptoms seem mild. Q: What warning signs shouldn't be ignored while using GLP-1 drugs? A: Persistent nausea, dizziness, confusion, trouble walking, vision changes, or extreme fatigue deserve immediate attention. These symptoms signal that energy metabolism is compromised and neurological injury may already be underway. Q: How can weight loss happen without these risks? A: Conversations about weight and metabolism often include the role of digestion, nutrition, and overall metabolic health. In my book, "Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1," I explore lifestyle and dietary concepts related to gut health, metabolism, and nutritional balance as part of an educational discussion. The book is intended for informational purposes only and does not provide medical advice or claim to diagnose, treat, cure, or prevent any disease. Test Your Knowledge with Today's Quiz! Take today\u2019s quiz to see how much you\u2019ve learned from yesterday\u2019s Mercola.com article. What part of the retina allows you to read fine print and recognize faces? Optic nerve Retina periphery Macular layer Foveola The foveola is the central part of the retina that provides the sharpest, most detailed vision, enabling tasks like reading and facial recognition. Learn more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx\" \/>\n<meta property=\"og:site_name\" content=\"Watchman News\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-23T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T05:43:01+00:00\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#article\",\"isPartOf\":{\"@id\":\"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f\"},\"headline\":\"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1\",\"datePublished\":\"2026-04-23T00:00:00+00:00\",\"dateModified\":\"2026-04-23T05:43:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/\"},\"wordCount\":2071,\"commentCount\":0,\"articleSection\":[\"Baptism & Confirmation\",\"Dr Mercola Daily News\"],\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/\",\"url\":\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx\",\"name\":\"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News\",\"isPartOf\":{\"@id\":\"https:\/\/watchman.news\/#website\"},\"datePublished\":\"2026-04-23T00:00:00+00:00\",\"dateModified\":\"2026-04-23T05:43:01+00:00\",\"author\":{\"@id\":\"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f\"},\"breadcrumb\":{\"@id\":\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/watchman.news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/watchman.news\/#website\",\"url\":\"https:\/\/watchman.news\/\",\"name\":\"Watchman News\",\"description\":\"News of Importance for the True Christian Israel\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/watchman.news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\/\/watchman.news\/nl\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx","og_locale":"nl_NL","og_type":"article","og_title":"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News","og_description":"A rare neurological emergency is reappearing in an unexpected place. Wernicke encephalopathy is a fast-moving brain disorder that emerges when cellular energy production breaks down, leaving your brain unable to function normally. Think of your brain as a city that runs entirely on electricity. Wernicke encephalopathy is what happens when the power grid starts failing \u2014 first in scattered neighborhoods, then spreading outward. The areas controlling balance, eye movement, and clear thinking go dark first because they're the most energy-hungry. What raises concern now is not the disorder itself, but the pattern behind recent cases. Powerful GLP-1 weight loss drugs like Ozempic have entered widespread use, and alongside that growth, clinicians have begun flagging severe neurological outcomes that don't fit the usual risk profile. Millions of people now rely on these injections to suppress appetite and drive rapid weight loss, often without understanding what prolonged appetite shutdown does to nutrient status and energy metabolism. At the center of this issue sits a simple but overlooked truth: your brain is the most fuel-hungry organ in your body, consuming 20% of your daily energy despite weighing only 2% of your body weight. Cut the fuel supply, and it's the first organ to suffer. When food intake collapses and digestion slows for weeks or months, the systems that convert glucose into energy begin to fail. Early warning signs often look vague and easy to dismiss, which is exactly why damage progresses before anyone realizes what's happening. This is where a gut-centered approach adds to the conversation. In my book, \"Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,\" I explore general lifestyle and nutrition concepts related to digestive health and metabolism. The book is intended for educational purposes only and does not claim to diagnose, treat, cure, or prevent any disease. Individual results may vary. A Rare Neurological Risk Surfaces in GLP-1 Drug Users A study published in Clinical Nutrition explored whether GLP-1 receptor agonist drugs used for weight loss and diabetes are associated with Wernicke encephalopathy, a severe neurological disorder tied to vitamin B1 deficiency.1 The researchers analyzed real-world safety data from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System and paired it with a structured review of published medical cases, which allows rare but serious harms to surface even when they don't appear in trials. \u2022 Researchers found 15 documented cases of Wernicke encephalopathy linked to GLP-1 drug use \u2014 Of them, 13 were reported through the FDA database, one from the medical literature, and one from the researchers' own hospital experience. Most reports clustered in 2023 and 2024, which mirrors the explosive rise in GLP-1 prescriptions. Reports of Wernicke encephalopathy were more than twice as likely with GLP-1 drugs compared with other medications. \u2022 Nearly every affected patient shared the same risk profile \u2014 Thirteen of the 15 individuals experienced severe gastrointestinal symptoms such as persistent vomiting, appetite loss, rapid weight loss, or malnutrition before neurological symptoms appeared. The study emphasizes that GLP-1 drugs slow gastric emptying and suppress appetite, which increases the likelihood of prolonged nutrient depletion. \u2022 Certain drugs appeared far more often than others \u2014 Eight of the 15 cases involved semaglutide, marketed as Ozempic or Wegovy, and six involved tirzepatide, sold under the brand name Mounjaro.2 \u2022 Classic neurological symptoms were often incomplete, which delayed diagnosis \u2014 Only two patients showed the full textbook triad of confusion, eye movement problems, and gait instability. Eleven showed partial symptoms, and some showed none at first. This matters because clinicians often wait for obvious signs before testing or treating vitamin B1 deficiency. Unlike fat-soluble vitamins that your body stores for months, vitamin B1 is water-soluble with minimal reserves \u2014 your body holds only about 30 milligrams at any time, enough for roughly two to three weeks. During rapid weight loss, metabolic demands actually increase while intake plummets, depleting stores at an accelerated rate. Among the 11 patients with follow-up data, seven were left with permanent neurological damage despite treatment. That means more than half experienced lasting harm that did not resolve even after vitamin B1 replacement. \u2022 The study highlights a glaring gap in current medical practice \u2014 Despite decades of awareness that rapid weight loss and vomiting trigger vitamin B1 deficiency in bariatric surgery patients, no formal guidelines require routine vitamin monitoring for people taking GLP-1 drugs for weight loss. For those taking GLP-1 drugs, recognizing early warning signs such as ongoing nausea, dizziness, confusion, or trouble walking allows timely vitamin B1 testing and treatment, which may reverse symptoms when done early. But the study raises a deeper question: why does B1 depletion cause such catastrophic damage so quickly? A commentary by bioenergetic researcher Georgi Dinkov provides the missing mechanistic piece.3 Why Energy Failure, Not Weight Loss, Drives the Real Danger In his commentary, Dinkov examines why vitamin B1 depletion creates cascading damage inside your brain and body once GLP-1 drugs suppress food intake and trigger prolonged vomiting. Dinkov explains that vitamin B1 controls pyruvate dehydrogenase (PDH), which acts like a metabolic turnstile at your cells' power plants. When B1 is adequate, PDH lets glucose pass through to produce clean, efficient energy. When B1 runs low, glucose gets diverted into an emergency backup pathway that produces lactic acid instead \u2014 the same substance that makes muscles burn during intense exercise. Except now it's building up in your brain. \u2022 Lactic acid builds up rapidly when PDH function drops \u2014 Impaired PDH activity forces glucose to convert into lactate instead of entering normal energy pathways. Lactate buildup damages tissues directly, especially in your brain and heart, and creates an internal acidic environment that cells struggle to survive. \u2022 The health consequences extend far beyond neurological symptoms alone. Dinkov links reduced PDH activity to a range of disorders, including depression, psychosis, diabetes, heart disease, and cancer, all tied to impaired glucose oxidation. Once lactic acid accumulates to dangerous levels, outcomes deteriorate fast. Severe lactic acidosis carries a reported mortality rate of 30% to 40% even with hospital treatment, which places metabolic collapse among the most lethal downstream effects of B1 depletion. \u2022 The risks don't disappear when symptoms look mild \u2014 Dinkov notes that even partial suppression of vitamin B1 activity still disrupts PDH function. Lower drug doses that blunt appetite without extreme vomiting still create metabolic stress that compounds over time. \u2022 Multiple established GLP-1 side effects intensify metabolic stress \u2014 Beyond appetite suppression, GLP-1 drugs associate with gastroparesis (delayed stomach emptying), vision loss, and other neurological complications, all of which reflect impaired energy production in tissues with high fuel demand. Delayed stomach emptying prolongs nausea, early fullness, and nutrient depletion, while visual damage signals ongoing metabolic failure in your nervous system. For patients, persistent digestive or sensory symptoms are not harmless trade-offs; they show that the metabolic imbalance driving harm remains active and uncorrected. How to Lose Weight Without Wrecking Your Metabolism Questions about long-term health often lead to broader discussions about lifestyle and metabolism. In my book, \"Weight Loss Cure,\" I explore general concepts related to nutrition, digestive health, and their role in metabolic function, from an educational perspective. The content does not provide medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical treatment decisions. 1. Stop using GLP-1 drugs and remove the metabolic stressor \u2014 If you're taking a GLP-1 drug, stopping it removes the constant pressure that suppresses appetite, slows digestion, and drains nutrients. Once that stress lifts, your body reallocates resources toward repair instead of survival. This single step protects your brain, stabilizes energy production, and prevents further nutrient depletion that drives neurological injury. 2. Use a GLP-1 strategy that works with your biology, not against it \u2014 A biology-informed approach can encourage broader conversations about metabolism. In my book, \"Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,\" I explore general lifestyle, nutrition, and digestive health concepts and their relationship to metabolic function. The book is educational in nature and does not claim to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical or treatment decisions. 3. Repair your gut so Akkermansia regulates appetite naturally \u2014 Akkermansia muciniphila is a key gut bacterium that helps trigger your body's own GLP-1 release through proteins it naturally secretes. When your gut barrier is damaged by seed oils, inflammation, and metabolic stress, this system shuts down. Fixing gut integrity first restores steady appetite control without malnutrition or energy failure. If your gut is not stable, repair comes before adding fiber or supplements. You might wonder what seed oils have to do with vitamin B1 and brain health. The connection is mitochondrial function. Seed oils high in linoleic acid (LA) create oxidative stress in your mitochondria \u2014 the same cellular power plants that B1 helps run. Eliminating one stressor while addressing another creates compounding benefits for energy production. 4. Create an environment where beneficial gut bacteria thrive \u2014 Eliminating seed oils high in LA reduces mitochondrial stress and gut inflammation, which allows Akkermansia to take hold. Aim to keep daily LA intake under 5 grams, ideally closer to 2 grams. When my Pax health coaching platform launches, the Seed Oil Sleuth feature will help you track this down to the tenth of a gram. Replace seed oils with grass fed butter, ghee, or tallow. After your digestion stabilizes, introduce polyphenol-rich foods such as berries and gentle inulin sources like leeks or garlic. Think of gut repair as building a house: you wouldn't install cabinets before the foundation is set. Each step creates the conditions for the next to succeed. 5. Restore protein and carbohydrates to rebuild energy and tissue \u2014 If your appetite stayed low for weeks or months, your body has been running on a deficit. Increase protein slowly until intake reaches about 0.8 grams per pound of ideal body weight (or about 1.76 grams per kilogram), with roughly one-third from collagen-rich sources such as bone broth, natural gelatin, oxtail, or connective-tissue-rich beef. Pair this with gradual carbohydrate reintroduction, starting with easy-to-digest options like fruit or white rice before moving to more complex carbs. Adequate glucose signals safety to your metabolism. Without it, your body stays in crisis mode \u2014 hoarding resources rather than investing them in repair. This is why low-carb diets often backfire during recovery. FAQs About GLP-1 Drugs and Neurological Risks Q: What is the main neurological risk linked to GLP-1 weight loss drugs? A: Recent clinical reports link GLP-1 drugs to Wernicke encephalopathy, a fast-moving brain disorder caused by severe vitamin B1 deficiency. When appetite suppression and slowed digestion persist, your brain loses the fuel it needs to function, leading to confusion, balance problems, vision changes, and lasting neurological damage. Q: Why do GLP-1 drugs increase the risk of vitamin B1 depletion? A: GLP-1 drugs suppress appetite and slow stomach emptying, which sharply reduces food intake and nutrient absorption over time. Prolonged nausea, vomiting, and early fullness drain vitamin B1 stores quickly, especially during rapid weight loss, setting the stage for energy failure in your brain. Q: Are these risks limited to high doses or severe side effects? A: No. Even lower doses that blunt appetite without obvious vomiting still create metabolic stress. Research and metabolic analysis show that partial nutrient depletion disrupts energy production and compounds damage over time, even when symptoms seem mild. Q: What warning signs shouldn't be ignored while using GLP-1 drugs? A: Persistent nausea, dizziness, confusion, trouble walking, vision changes, or extreme fatigue deserve immediate attention. These symptoms signal that energy metabolism is compromised and neurological injury may already be underway. Q: How can weight loss happen without these risks? A: Conversations about weight and metabolism often include the role of digestion, nutrition, and overall metabolic health. In my book, \"Weight Loss Cure: Melt Fat Naturally with Your Own GLP-1,\" I explore lifestyle and dietary concepts related to gut health, metabolism, and nutritional balance as part of an educational discussion. The book is intended for informational purposes only and does not provide medical advice or claim to diagnose, treat, cure, or prevent any disease. Test Your Knowledge with Today's Quiz! Take today\u2019s quiz to see how much you\u2019ve learned from yesterday\u2019s Mercola.com article. What part of the retina allows you to read fine print and recognize faces? Optic nerve Retina periphery Macular layer Foveola The foveola is the central part of the retina that provides the sharpest, most detailed vision, enabling tasks like reading and facial recognition. Learn more.","og_url":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx","og_site_name":"Watchman News","article_published_time":"2026-04-23T00:00:00+00:00","article_modified_time":"2026-04-23T05:43:01+00:00","author":"Admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Admin","Geschatte leestijd":"10 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#article","isPartOf":{"@id":"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/"},"author":{"name":"Admin","@id":"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f"},"headline":"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1","datePublished":"2026-04-23T00:00:00+00:00","dateModified":"2026-04-23T05:43:01+00:00","mainEntityOfPage":{"@id":"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/"},"wordCount":2071,"commentCount":0,"articleSection":["Baptism & Confirmation","Dr Mercola Daily News"],"inLanguage":"nl-NL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#respond"]}]},{"@type":"WebPage","@id":"https:\/\/watchman.news\/2026\/04\/glp-1-weight-loss-drugs-trigger-a-life-threatening-brain-condition-by-depleting-vitamin-b1\/","url":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx","name":"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1 - Watchman News","isPartOf":{"@id":"https:\/\/watchman.news\/#website"},"datePublished":"2026-04-23T00:00:00+00:00","dateModified":"2026-04-23T05:43:01+00:00","author":{"@id":"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f"},"breadcrumb":{"@id":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2026\/04\/23\/glp1-depleting-vitamin-b1.aspx#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/watchman.news\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Weight Loss Drugs Trigger a Life-Threatening Brain Condition by Depleting Vitamin B1"}]},{"@type":"WebSite","@id":"https:\/\/watchman.news\/#website","url":"https:\/\/watchman.news\/","name":"Watchman Nieuws","description":"News of Importance for the True Christian Israel","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/watchman.news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/watchman.news\/#\/schema\/person\/3f4506c6002f5893ba45478a4540739f","name":"beheerder","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4dc65c7d54b24b8fa9d6d4116fd21209e86efe3563858469b00d8bddd033356?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/watchman.news\/nl\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/posts\/164052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/comments?post=164052"}],"version-history":[{"count":0,"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/posts\/164052\/revisions"}],"wp:attachment":[{"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/media?parent=164052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/categories?post=164052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/watchman.news\/nl\/wp-json\/wp\/v2\/tags?post=164052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}